Exposure to lead in early childhood may be associated with an increased risk for sleep problems and excessive daytime sleepiness.
Jianghong Liu, PhD, of the University of Pennsylvania’s Perelman School of Medicine, and colleagues examined data from a longitudinal, cohort study that began in 2004 of more than 1,400 children from China to investigate the impact of lead exposure on children’s neurocognitive, behavioral, and physical development. Lead pollution is a serious problem in China.
Lead levels in the blood of 665 children was assessed when they were between three and five years old, and sleep was assessed when they were between nine and 11 years old. Children and their parents also answered questionnaires about sleep patterns, insomnia, and if they used sleeping pills.
Children who had high blood lead levels reported insomnia and use of sleeping pills were, respectively, two times and three times higher, compared to children with lower levels of lead in their blood, the researchers reported in the journal SLEEP.
“Little is known about the impact of heavy metals exposure on children’s sleep, but the study’s findings highlight that environmental toxins, such as lead, are important pediatric risk factors for sleep disturbance,” Liu said in a statement.
A new study has linked exposure to lead in early childhood with an increased risk for sleep problems and excessive daytime sleepiness in early childhood.
The new study from the University of Pennsylvania School of Nursing is based on data from a longitudinal, cohort study that began in 2004 involving more than 1,400 Chinese children to investigate how lead exposure influences children’s neurocognitive, behavioral, and physical health development.
Lead pollution is pervasive throughout China and other developing countries, said the researchers, who noted that while rates of lead exposure are decreasing due to the phase-out of leaded gasoline and increased public awareness, its persistence presents a significant health risk to children.
Enjoying our content?
Thanks for visiting Psychiatry Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Psychiatry Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Evidence-Based Guidance
- Conference Coverage
- Unique Psychiatry Case Studies
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.